Drugs that contain Meropenem; Vaborbactam

1. Drug name - VABOMERE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8680136 REMPEX Cyclic boronic acid ester derivatives and therapeutic uses thereof
Aug, 2031

(8 years from now)

CN103180328B REMPEX Cyclic Borate Ester Derivatives And Therapeutic Use Thereof Formula Refers To Dda00002980358600011.Gif
Aug, 2031

(8 years from now)

CN103180328A REMPEX Ring Boron Acid Ester Derivatives And Their Therapeutic Use
Aug, 2031

(8 years from now)

IN391496B REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

IN201301146P1 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP3666778A1 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP3666778B1 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP3412676A1 REMPEX Cyclic Boronic Acid Ester Derivatives, Method For The Preparation And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP3412676B1 REMPEX Cyclic Boronic Acid Ester Derivatives, Method For The Preparation And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP2603514A1 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP2603514B1 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

EP2603514A4 REMPEX Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
Aug, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9694025 REMPEX Cyclic boronic acid ester derivatives and therapeutic uses thereof Aug, 2031

(8 years from now)

US10183034 REMPEX Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives Aug, 2031

(8 years from now)

US10561675 REMPEX Cyclic boronic acid ester derivatives and therapeutic uses thereof Aug, 2031

(8 years from now)

US11007206 REMPEX Cyclic boronic acid ester derivatives and therapeutic uses thereof Aug, 2031

(8 years from now)

US10172874 REMPEX Pharmaceutical compositions comprising cyclic boronic acid ester derivatives Aug, 2031

(8 years from now)

Treatment: Treatment of patients 18 years of age and older with complicated urinary tract infections caused by susceptible microorganisms; Treatment of complicated urinary tract infection (cuti) including pyelonephritis caused by the following susceptible microorganisms: escherichia coli, klebsiella pneumonia, and enterobacter cloacae species complex; Treatment of complicated urinary tract infections (cuti) including pyelonephritis caused by the following susceptible microorganisms: escherichia coli, klebsiella pneumonia, enterobacter cloacae species complex with meropenem & vaborbactam as specified

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
1GM/VIAL;1GM/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.